UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Advances in the Treatment of EGFR Exon 20ins Mutant NSCLC

Zhongguo fei ai za zhi, 2023-02, Vol.26 (2), p.151-157

2023

Volltextzugriff (PDF)

Efficacy Differences of First-line EGFR-TKIs Alone vs in Combination with Chemotherapy in Advanced Lung Adenocarcinoma Patients with Sensitive EGFR Mutation and Concomitant Non-EGFR Genetic Alterations

Zhongguo fei ai za zhi, 2022-09, Vol.25 (9), p.651-657

2022

Volltextzugriff (PDF)

Advances in ICIs Therapy after TKIs Resistance in Patients with EGFR Mutant NSCLC: A Review

Zhongguo fei ai za zhi, 2022, Vol.25 (8), p.601-608

2022

Volltextzugriff (PDF)

Association between EGFR, ALK and KRAS Gene Status and Synchronous Distant  Organ Metastasis in Non-small Cell Lung Cancer

Zhongguo fei ai za zhi, 2018-07, Vol.21 (7), p.536-542

2018

Volltextzugriff (PDF)

Analysis of the Effcacy and Safety of Amivantamab in Non-small Cell Lung Cancer Patients with EGFR/MET Gene Abnormalities: A Single Center’s Experience

Zhongguo fei ai za zhi, 2022-07, Vol.25 (7), p.493-500

2022

Volltextzugriff (PDF)

Correlation between Immune Microenvironment Features and EGFR Mutation Status  in Lung Adenocarcinoma

Zhongguo fei ai za zhi, 2023-03, Vol.26 (3), p.204-216

2023

Volltextzugriff (PDF)

EGFR突变的肺腺癌患者中Rb和磷酸化Rb的表达及临床特征分析

中国肺癌杂志, 2017, Vol.20 (5), p.312-317

董云龙刘明辉李永文李颖赵辰龙袁茵杜晖张子禾张洪兵刘红雨陈军

2017

Volltextzugriff (PDF)

Research Progress of Proteolysis Targeting Chimeria in NSCLC Therapy

Zhongguo fei ai za zhi, 2022-07, Vol.25 (7), p.477-481

2022

Volltextzugriff (PDF)

EGFR基因状态与晚期非小细胞肺癌患者一线化疗疗效的关系

中国肺癌杂志, 2015, Vol.18 (3), p.131-137

秦娜张权王敬慧张卉顾艳斐杨新杰李曦吕嘉林吴羽华农靖颖张新勇张树才

2015

Volltextzugriff (PDF)

Effect of apigenin in combination with oxymatrine on non-small cell lung cancer and mechanism

Zhongguo zhongyao zazhi, 2023-02, Vol.48 (3), p.752

2023

Volltextzugriff (PDF)

EGFR-TKI对肺癌新生淋巴管的影响及其意义

中国肺癌杂志, 2014, Vol.17 (12), p.834-838

蔡明辉杨新颖姜宝红滕福康潘雁毛锋申屠阳

2014

Volltextzugriff (PDF)

Nrf2在EGFR基因突变肺腺癌中的表达及其与EGFR-TKIs疗效间的相关性研究

中国肺癌杂志, 2014, Vol.17 (2), p.155-162

朱翔梁莉柳晨尹文琤陈森曹宝山

2014

Volltextzugriff (PDF)

Acquired Drug Resistance Mechanism of Osimertinib in the Targeted Therapy of Non-small Cell Lung Cancer

Zhongguo Fei Ai Za Zhi, 2020-04, Vol.23 (4), p.274-281

2020

Volltextzugriff (PDF)

Non-small Cell Lung Cancer with Metachronous Mutations of EGFR and ALK Genes:  A Case Report and Literature Review

Zhongguo fei ai za zhi, 2024-07, Vol.27 (7), p.559-564

2024

Volltextzugriff (PDF)

Chinese Expert Consensus on the Standardized Diagnosis and Treatment of  Non‑small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations (2024 Edition)

Zhongguo fei ai za zhi, 2024-07, Vol.27 (7), p.485-494

Chinese Society of Clinical Oncology Non-small Cell Lung Cancer Committee

2024

Volltextzugriff (PDF)

非小细胞肺癌脑膜转移的临床病理特征及预后分析

中国肺癌杂志, 2016, Vol.19 (8), p.533-538

朱敏任雁宏刘艳班承钧顾华王征张予辉

2016

Volltextzugriff (PDF)

非小细胞肺癌外周血游离DNA及肿瘤细胞EGFR基因突变检测方法的研究进展

中国肺癌杂志, 2016, Vol.19 (11), p.766-772

张雨徐燕王孟昭

2016

Volltextzugriff (PDF)

Progress of Immunotherapy in EGFR-mutated Advanced Non-small Cell Lung Cancer

Zhongguo fei ai za zhi, 2024-01, Vol.26 (12), p.934-942

2024

Volltextzugriff (PDF)

EGFR—TKI联合放疗治疗晚期非小细胞肺癌的研究进展

中国肺癌杂志, 2014, Vol.17 (4), p.357-362

李夏南朱广迎

2014

Volltextzugriff (PDF)

Symptomatic Radiation Pneumonitis in NSCLC Patients Receiving EGFR-TKIs and Concurrent Once-daily Thoracic Radiotherapy: Predicting the Value of Clinical and Dose-volume Histogram Parameters

Zhongguo fei ai za zhi, 2022-06, Vol.25 (6), p.409-419

2022

Volltextzugriff (PDF)

Characteristics of Epidermal Growth Factor Receptor with Rare Mutations in Non-small Cell Lung Cancer and the Effect of EGFR Tyrosine Kinase Inhibitors on Them

Zhongguo fei ai za zhi, 2019-05, Vol.22 (5), p.299-305

2019

Volltextzugriff (PDF)

Clinical Features of EGFR Double Mutation in Non-small Cell Lung Cancer

Zhongguo fei ai za zhi, 2018-08, Vol.21 (8), p.594-599

2018

Volltextzugriff (PDF)

Clinical Evaluation of A New Pathological Classification for  Non-small Cell Lung Cancer Based on Histogenesis of Bronchial Tree

Zhongguo fei ai za zhi, 2018-07, Vol.21 (7), p.530-535

2018

Volltextzugriff (PDF)

754例Ⅰ期-Ⅲa期可手术切除非小细胞肺癌患者EGFR和KRAS基因突变状态及其临床意义

中国肺癌杂志, 2017, Vol.20 (9), p.617-622

赵静高洁郭李平胡晓许刘琦赵金银刘利成姜君王孟昭梁智勇徐燕陈闽江张力李龙芸钟巍

2017

Volltextzugriff (PDF)

晚期非小细胞肺癌靶向治疗进展与展望：聚焦小分子酪氨酸激酶抑制剂

中国肺癌杂志, 2017, Vol.20 (4), p.278-286

张国伟王慧娟马智勇

2017

Volltextzugriff (PDF)

1 – 25 von 215

Suche als RSS-Feed

Aktive Filter

SpracheChinesisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(173)
Mit Volltextzugriff
(190)

Publikationsform

Artikel
(215)

Sprache

Englisch
(8)

Erscheinungsjahr

n.n

Thema

Egfr
(95)
Humans
(94)
Lung Neoplasms
(89)
Mutation
(72)
Lung Cancer
(69)
Epidermal Growth Factor
(57)
Lung Neoplasms - Drug Therapy
(54)
Lung Neoplasms - Genetics
(52)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(45)
Carcinoma, Non-Small-Cell Lung - Genetics
(42)
Male
(42)
Female
(40)
肺肿瘤
(40)
Cancer Therapies
(39)
Middle Aged
(38)
Protein Kinase Inhibitors - Therapeutic Use
(36)
Chemotherapy
(33)
Aged
(31)
Erbb Receptors - Genetics
(31)
Lung Neoplasms - Pathology
(31)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Advances in the Treatment of EGFR Exon 20ins Mutant NSCLC

Efficacy Differences of First-line EGFR-TKIs Alone vs in Combination with Chemotherapy in Advanced Lung Adenocarcinoma Patients with Sensitive EGFR Mutation and Concomitant Non-EGFR Genetic Alterations

Advances in ICIs Therapy after TKIs Resistance in Patients with EGFR Mutant NSCLC: A Review

Association between EGFR, ALK and KRAS Gene Status and Synchronous Distant  Organ Metastasis in Non-small Cell Lung Cancer

Analysis of the Effcacy and Safety of Amivantamab in Non-small Cell Lung Cancer Patients with EGFR/MET Gene Abnormalities: A Single Center’s Experience

Correlation between Immune Microenvironment Features and EGFR Mutation Status  in Lung Adenocarcinoma

EGFR突变的肺腺癌患者中Rb和磷酸化Rb的表达及临床特征分析

Research Progress of Proteolysis Targeting Chimeria in NSCLC Therapy

EGFR基因状态与晚期非小细胞肺癌患者一线化疗疗效的关系

Effect of apigenin in combination with oxymatrine on non-small cell lung cancer and mechanism

EGFR-TKI对肺癌新生淋巴管的影响及其意义

Nrf2在EGFR基因突变肺腺癌中的表达及其与EGFR-TKIs疗效间的相关性研究

Acquired Drug Resistance Mechanism of Osimertinib in the Targeted Therapy of Non-small Cell Lung Cancer

Non-small Cell Lung Cancer with Metachronous Mutations of EGFR and ALK Genes:  A Case Report and Literature Review

Chinese Expert Consensus on the Standardized Diagnosis and Treatment of  Non‑small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations (2024 Edition)

非小细胞肺癌脑膜转移的临床病理特征及预后分析

非小细胞肺癌外周血游离DNA及肿瘤细胞EGFR基因突变检测方法的研究进展

Progress of Immunotherapy in EGFR-mutated Advanced Non-small Cell Lung Cancer

EGFR—TKI联合放疗治疗晚期非小细胞肺癌的研究进展

Symptomatic Radiation Pneumonitis in NSCLC Patients Receiving EGFR-TKIs and Concurrent Once-daily Thoracic Radiotherapy: Predicting the Value of Clinical and Dose-volume Histogram Parameters

Characteristics of Epidermal Growth Factor Receptor with Rare Mutations in Non-small Cell Lung Cancer and the Effect of EGFR Tyrosine Kinase Inhibitors on Them

Clinical Features of EGFR Double Mutation in Non-small Cell Lung Cancer

Clinical Evaluation of A New Pathological Classification for  Non-small Cell Lung Cancer Based on Histogenesis of Bronchial Tree

754例Ⅰ期-Ⅲa期可手术切除非小细胞肺癌患者EGFR和KRAS基因突变状态及其临床意义

晚期非小细胞肺癌靶向治疗进展与展望：聚焦小分子酪氨酸激酶抑制剂

Aktive Filter

Suchergebnisse filtern